LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Fate Therapeutics (NASDAQ: FATE)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ FATE Fate Therapeutics
Redmile Group, LLC / director, 10 percent owner:
12/20/2024
Buy
$1.68
397,964
$669K
12.88M
NASDAQ FATE Fate Therapeutics
Redmile Group, LLC / director, 10 percent owner:
12/20/2024
Buy
$1.68
1.08M
$1.823M
12.83M
NASDAQ FATE Fate Therapeutics
Redmile Group, LLC / director, 10 percent owner:
12/20/2024
Sell
$1.68
341,633
$574K
12.49M
NASDAQ FATE Fate Therapeutics
Redmile Group, LLC / director, 10 percent owner:
12/20/2024
Sell
$1.68
1.08M
$1.823M
11.74M
NASDAQ FATE Fate Therapeutics
Redmile Group, LLC / director, 10 percent owner:
12/20/2024
Sell
$3.02
56,331
$170K
502,769
NASDAQ FATE Fate Therapeutics
Redmile Group, LLC / director, 10 percent owner:
12/12/2024
Buy
$0.001
30,110
$30
12.83M